How Syndromic Testing Allows Labs to Do More with Less
Syndromic testing provides labs flexibility, maximizes equipment and personnel resources, and helps control costs.
Read MorePosted by Chris Wolski | Dec 1, 2022 | Flu & Respiratory Infections, Molecular Diagnostics |
Syndromic testing provides labs flexibility, maximizes equipment and personnel resources, and helps control costs.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read MorePosted by Andy Lundin | Nov 23, 2022 | Emerging & Zoonotic Diseases |
Qiagen launched a monkeypox test for its NeuMoDx automated PCR platform to strengthen surveillance and research into the current outbreak.
Read MorePosted by Chris Wolski | Nov 22, 2022 | Company News |
COLA announces the American Medical Association’s (AMA) appointment of Madelyn E. Butler, MD, to COLA’s Board of Directors.
Read MorePosted by Chris Wolski | Nov 22, 2022 | Unknown Origin & Other Cancer Types |
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.
Read More